FEDERAL COURT OF AUSTRALIA
Bell IXL Investments Ltd v Life Therapeutics Ltd [2008] FCA 1457
CORPORATIONS – directors’ duties – acting for a proper purpose – where plaintiff a shareholder in first defendant - where plaintiff requisitioned first defendant to convene an extraordinary general meeting of shareholders to consider a resolution to remove board of first defendant and replace it with three persons nominated by plaintiff – where first defendant subsequently issued new shares – whether new share issue was made for purpose of defeating plaintiff’s resolution and therefore improper – assessment of evidence and credit of directors of first defendant – Briginshaw principle – difference between inference and conjecture
WORDS AND PHRASES – “proper purpose” – “improper purpose”
Ashburton Oil NL v Alpha Minerals NL (1971) 123 CLR 614 cited
Briginshaw v Briginshaw (1938) 60 CLR 336 discussed
Harlowe’s Nominees Pty Ltd v Woodside (Lakes Entrance) Oil Company NL (1968) 121 CLR 483 referred to
Howard Smith Ltd v Ampol Petroleum Ltd [1974] 1 NSWLR 68 referred to
Idameneo (No 123) Pty Ltd v Symbion Health Ltd (2007) 64 ACSR 680 referred to
Jones v Dunkel (1959) 101 CLR 298 followed
Langton v Forsayth Mineral Exploration NL (1975) 1 ACLR 227 cited
Neat Holdings Pty Ltd v Karajan Holdings Pty Ltd (1992) 110 ALR 449 discussed
Ngurli Ltd v McCann (1953) 90 CLR 425 cited
Re Southern Resources Ltd (No 2) (1989) 15 ACLR 770 cited
Whitehouse v Carlton Hotel Pty Ltd (1987) 162 CLR 285 citedBELL IXL INVESTMENTS LIMITED (ACN 113 669 908) v LIFE THERAPEUTICS LIMITED (ACN 001 001 145), AEGIS PARTNERS LIMITED and BELL POTTER NOMINEES LIMITED (ACN 088 899 601)
VID 432 OF 2008
MIDDLETON J
26 SEPTEMBER 2008
MELBOURNE
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
VID 432 OF 2008
BETWEEN:
BELL IXL INVESTMENTS LIMITED (ACN 113 669 908)
Plaintiff
AND:
LIFE THERAPEUTICS LIMITED (ACN 001 001 145)
First DefendantAEGIS PARTNERS LIMITED
Second DefendantBELL POTTER NOMINEES LIMITED (ACN 088 899 601)
Third Defendant
JUDGE:
MIDDLETON J
DATE OF ORDER:
26 SEPTEMBER 2008
WHERE MADE:
MELBOURNE
THE COURT ORDERS THAT:
1.The parties confer and then file and serve by 4.00 pm on 3 October 2008:
(a)any submissions as to the appropriate orders to make and as to costs (including costs of and incidental to the trial before Finkelstein J);
(b)any submissions (and evidence) on the question of whether there should be an order:
(i)that a new general meeting be held with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); or
(ii)alternatively, that the adjourned meeting be conducted upon notice with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); and
(c)any submissions on any further orders consequential upon dismissal of the proceeding (including any orders permitting the general meeting to proceed).
2.Any further hearing on the outstanding matters be adjourned to a date…
Keep reading for free
Create a free CaseChat account to read Bell IXL Investments Ltd v Life Therapeutics Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2008] FCA 1457
- Decision Date
CaseChat Overview and Summary
The court considered the evidence presented by both parties, including the documentary material and the testimonies of the directors and other involved parties. The directors and Mr Waller of Aegis provided their testimonies, which the court found to be honest and credible. The court noted that the lack of written documentation did not undermine the credibility of the directors' evidence, as it was not their practice to document every discussion or decision. The court concluded that the allotment was made based on a commercial basis and was appropriate as a matter of business judgment.
After evaluating the evidence, the court found that the purpose of the allotment was not as described by the plaintiff. The court concluded that the allotment was made in the best interests of Life Therapeutics Ltd, and not for an improper purpose. Consequently, the court dismissed the proceeding and ordered the parties to confer and submit further submissions on the appropriate orders to make, including any consequential orders and the possibility of holding a new general meeting.
Orders
Orders of the court
1. The parties confer and then file and serve by 4.00 pm on 3 October 2008:
(a) any submissions as to the appropriate orders to make and as to costs (including costs of and incidental to the trial before Finkelstein J);
(b) any submissions (and evidence) on the question of whether there should be an order:
(i) that a new general meeting be held with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); or
(ii) alternatively, that the adjourned meeting be conducted upon notice with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); and
(c) any submissions on any further orders consequential upon dismissal of the proceeding (including any orders permitting the general meeting to proceed).
2. Any further hearing on the outstanding matters be adjourned to a date to be fixed.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Established by: MIDDLETON J